Alzamend Neuro, Inc.
ALZN
$2.96
-$0.03-1.00%
NASDAQ
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.14M | -985.80K | -1.42M | -974.40K | -851.50K |
| Total Depreciation and Amortization | 12.70K | 12.70K | 12.70K | 12.70K | 12.70K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 81.30K | 81.30K | 81.30K | 90.60K | 82.00K |
| Change in Net Operating Assets | 356.80K | -531.80K | -2.08M | -184.60K | -669.90K |
| Cash from Operations | -688.70K | -1.42M | -3.40M | -1.06M | -1.43M |
| Capital Expenditure | -210.00K | 0.00 | 0.00 | -90.00K | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -210.00K | 0.00 | 0.00 | -90.00K | 0.00 |
| Total Debt Issued | -- | -- | -- | -- | 300.00K |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 841.70K | 688.70K | 1.17M | -- | 269.90K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 647.50K | 0.00 | 5.13M | 1.96M | 950.00K |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1.49M | 688.70K | 6.30M | 1.96M | 1.52M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 590.50K | -734.90K | 2.90M | 817.90K | 93.20K |